# Intellia Therapeutics, Inc.: Form 8-K, filed Apr 7, 2025

- Company: [Intellia Therapeutics, Inc.](/companies/ntla.md) (CIK 1652130)
- Form: 8-K
- Filed: 2025-04-07
- Accepted by EDGAR: Apr 7, 2025, 06:05 ET
- Period: 2025-04-03
- Accession: 0001193125-25-073904
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/d901196d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/d901196d8k.htm

Filed Apr 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-073904. Last ingested by Listed: Nov 5, 2026, 17:50 ET. No prices; not investment advice.